Saira Ramasastry - 19 May 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Director
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 19 May 2021
Net transactions value: -$309,675
Form type: 4
Filing time: 20 May 2021, 19:54:03 UTC
Next filing: 25 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$127,600	+10,000		$12.76	10,000	19 May 2021	Direct
transaction	VIR	Common Stock	Sale	$437,275	-10,000	-100%	$43.73	0	19 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-17%	$0.000000	47,777	19 May 2021	Common Stock	10,000	$12.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2021.
F2	1/3 of the shares subject to the stock option vested and became exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter.